ID   CBR1_MACFA              Reviewed;         277 AA.
AC   Q8MI29;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   02-DEC-2020, entry version 78.
DE   RecName: Full=Carbonyl reductase [NADPH] 1;
DE            EC=1.1.1.184;
DE   AltName: Full=15-hydroxyprostaglandin dehydrogenase [NADP(+)];
DE            EC=1.1.1.141 {ECO:0000250|UniProtKB:Q28960};
DE            EC=1.1.1.197;
DE   AltName: Full=20-beta-hydroxysteroid dehydrogenase {ECO:0000250|UniProtKB:Q28960};
DE   AltName: Full=NADPH-dependent carbonyl reductase 1;
DE            EC=1.1.1.53 {ECO:0000250|UniProtKB:Q28960};
DE   AltName: Full=Prostaglandin 9-ketoreductase {ECO:0000250|UniProtKB:Q28960};
DE            Short=PG-9-KR {ECO:0000250|UniProtKB:Q28960};
DE   AltName: Full=Prostaglandin-E(2) 9-reductase {ECO:0000250|UniProtKB:Q28960};
DE            EC=1.1.1.189 {ECO:0000250|UniProtKB:Q28960};
GN   Name=CBR1; Synonyms=PGDH2;
OS   Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
OC   Cercopithecidae; Cercopithecinae; Macaca.
OX   NCBI_TaxID=9541;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cornea;
RA   Fujimori K., Okada T., Habe T., Osama H., Urade Y.;
RT   "Cloning of prostaglandin dehydrogenase type I cDNA from monkey.";
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: NADPH-dependent reductase with broad substrate specificity.
CC       Catalyzes the reduction of a wide variety of carbonyl compounds
CC       including quinones, prostaglandins, menadione, plus various
CC       xenobiotics. Catalyzes the reduction of the antitumor anthracyclines
CC       doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol
CC       and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-
CC       alpha (By similarity). Can bind glutathione, which explains its higher
CC       affinity for glutathione-conjugated substrates. Catalyzes the reduction
CC       of S-nitrosoglutathione (By similarity). {ECO:0000250|UniProtKB:P16152,
CC       ECO:0000250|UniProtKB:Q28960}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a secondary alcohol + NADP(+) = a ketone + H(+) + NADPH;
CC         Xref=Rhea:RHEA:19257, ChEBI:CHEBI:15378, ChEBI:CHEBI:17087,
CC         ChEBI:CHEBI:35681, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.184;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + prostaglandin F2alpha = H(+) + NADPH + prostaglandin
CC         E2; Xref=Rhea:RHEA:24508, ChEBI:CHEBI:15378, ChEBI:CHEBI:57404,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:606564;
CC         EC=1.1.1.189; Evidence={ECO:0000250|UniProtKB:Q28960};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:24510;
CC         Evidence={ECO:0000250|UniProtKB:Q28960};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NADP(+) + prostaglandin E1 = 15-oxoprostaglandin E1 + H(+) +
CC         NADPH; Xref=Rhea:RHEA:11636, ChEBI:CHEBI:15378, ChEBI:CHEBI:57397,
CC         ChEBI:CHEBI:57401, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         EC=1.1.1.197;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + prostaglandin E2 = 15-oxoprostaglandin E2 + H(+) +
CC         NADH; Xref=Rhea:RHEA:11876, ChEBI:CHEBI:15378, ChEBI:CHEBI:57400,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:606564;
CC         EC=1.1.1.141; Evidence={ECO:0000250|UniProtKB:Q28960};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=androstan-3alpha,17beta-diol + NAD(+) = 17beta-
CC         hydroxyandrostanone + H(+) + NADH; Xref=Rhea:RHEA:22400,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:18011, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945, ChEBI:CHEBI:85278; EC=1.1.1.53;
CC         Evidence={ECO:0000250|UniProtKB:Q28960};
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q28960}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q28960}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB059654; BAB97216.1; -; mRNA.
DR   RefSeq; NP_001306427.1; NM_001319498.1.
DR   SMR; Q8MI29; -.
DR   STRING; 9541.XP_005548781.1; -.
DR   GeneID; 102141127; -.
DR   KEGG; mcf:102141127; -.
DR   eggNOG; KOG1208; Eukaryota.
DR   BRENDA; 1.1.1.197; 1793.
DR   Proteomes; UP000233100; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016404; F:15-hydroxyprostaglandin dehydrogenase (NAD+) activity; IEA:UniProtKB-EC.
DR   GO; GO:0047021; F:15-hydroxyprostaglandin dehydrogenase (NADP+) activity; ISS:UniProtKB.
DR   GO; GO:0047044; F:androstan-3-alpha,17-beta-diol dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004090; F:carbonyl reductase (NADPH) activity; ISS:UniProtKB.
DR   GO; GO:0050221; F:prostaglandin-E2 9-reductase activity; ISS:UniProtKB.
DR   GO; GO:0017144; P:drug metabolic process; ISS:UniProtKB.
DR   GO; GO:0042373; P:vitamin K metabolic process; ISS:UniProtKB.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   Pfam; PF00106; adh_short; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   2: Evidence at transcript level;
KW   Cytoplasm; NADP; Oxidoreductase; Phosphoprotein; Reference proteome.
FT   CHAIN           1..277
FT                   /note="Carbonyl reductase [NADPH] 1"
FT                   /id="PRO_0000284144"
FT   NP_BIND         10..34
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   NP_BIND         63..64
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   NP_BIND         194..198
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   NP_BIND         231..233
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   REGION          95..97
FT                   /note="Glutathione binding"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   REGION          193..194
FT                   /note="Glutathione binding"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   ACT_SITE        194
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         90
FT                   /note="NADP; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   BINDING         106
FT                   /note="Glutathione"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   BINDING         140
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P16152"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48758"
SQ   SEQUENCE   277 AA;  30473 MW;  3C93FD111F778C60 CRC64;
     MKSGIRVALV TGSNKGIGLA IVRDLCRLFS GEVVLTARDV ARGQAAVQQL QAEGLSPRFH
     QLDIDDLQSI RTLRDFLLKE YGGLDVLVNN AGIAFKVADP TPFHIQAEVT MKTNFFGTRD
     VCTELLPLIK PQGRVVNISS MMSLRALKSC SPELQQKFRS ETITEEELVG LMNKFAEDTK
     KGVHQKEGWP SSAYGVTKIG VTVLSRIHAR KLSEQRKGDK ILLNACCPGW VRTDMAGPSA
     TKSPEEGAET PVYLALLPLD AEGPHGQFVM EKRVEQW
//
